Sanofi Consumer Healthcare India (NSE:SANOFICONR) Ending Cash Position: ₹4,906 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SANOFICONR Sanofi Consumer Healthcare India Ltd NSE:SANOFICONR
24 GF Score
Price ₹3,997.60
! 2 Warning Signs
View Full Analysis

What is Sanofi Consumer Healthcare India Ending Cash Position?

Sanofi Consumer Healthcare India NSE:SANOFICONR +1.10% 24 Ending Cash Position is ₹4,906 Mil as of Jun. 2026. GuruFocus rates NSE:SANOFICONR with a GF Score™ of 24/100. The stock has 2 warning signs investors should review.

Sanofi Consumer Healthcare India's Ending Cash Position for the quarter that ended in Jun. 2026 was ₹4,906 Mil.

Sanofi Consumer Healthcare India's quarterly Ending Cash Position declined from Dec. 2025 (₹3,752 Mil) to Mar. 2026 (₹ Mil) but then increased from Mar. 2026 (₹ Mil) to Jun. 2026 (₹4,906 Mil).

Sanofi Consumer Healthcare India's annual Ending Cash Position increased from Dec. 2023 (₹16 Mil) to Dec. 2024 (₹3,269 Mil) and increased from Dec. 2024 (₹3,269 Mil) to Dec. 2025 (₹3,752 Mil).

Sanofi Consumer Healthcare India Ending Cash Position Related Terms

Sanofi Consumer Healthcare India Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Sanofi Consumer Healthcare India's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sanofi Consumer Healthcare India Ending Cash Position Chart

Sanofi Consumer Healthcare India Annual Data
Trend Dec23 Dec24 Dec25
Ending Cash Position
16.00 3,269.00 3,752.00

Sanofi Consumer Healthcare India Quarterly Data
Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,169.00 - 3,752.00 - 4,906.00
NSE:SANOFICONR
24GF Score
Sanofi Consumer Healthcare India Ltd NSE:SANOFICONR
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sanofi Consumer Healthcare India Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Sanofi Consumer Healthcare India's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=3269+483
=3,752

Sanofi Consumer Healthcare India's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=4906+
=4,906

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of ₹4,906 Mil mean?
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a Ending Cash Position of ₹4,906 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Sanofi Consumer Healthcare India and its competitors.
Is Sanofi Consumer Healthcare India's Ending Cash Position too high?
Sanofi Consumer Healthcare India's current Ending Cash Position is ₹4,906 Mil. Overall, Sanofi Consumer Healthcare India has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Sanofi Consumer Healthcare India's Ending Cash Position compare to LLY and JNJ?
Sanofi Consumer Healthcare India's Ending Cash Position of ₹4,906 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Sanofi Consumer Healthcare India and its competitors. Sanofi Consumer Healthcare India's current Ending Cash Position is ₹4,906 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanofi Consumer Healthcare India stock overvalued right now?
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a current Ending Cash Position of ₹4,906 Mil. The current Ending Cash Position is ₹4,906 Mil. Sanofi Consumer Healthcare India's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Sanofi Consumer Healthcare India (NSE:SANOFICONR), the current Ending Cash Position is ₹4,906 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sanofi Consumer Healthcare India Business Description

Other Exchanges 544250:India
Address Pirojshanagar, Eastern Express Highway, Unit 1104, 11th Floor, Godrej Two, Vikhroli East, Mumbai, MH, IND, 400079
Sanofi Consumer Healthcare India Ltd is mainly engaged in the business of manufacturing and trading of drugs and pharmaceutical products. The Company also has various independent contract/third-party manufacturers based across the country and provides business support services to its group entity in India. Its products include Allergy Relief (Allegra), Pain Care (Combiflam), and Physical Wellness (DePURA). The Company sells its products in India through independent distributors and outside India. Its operations are limited to one segment, namely Pharmaceutical Business. The Company operates in India, which generates the maximum revenue, and Outside India.
24GF Score

Get the complete analysis for NSE:SANOFICONR

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3,997.60
Price